+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: Role of physical activity and unmet medical need



Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: Role of physical activity and unmet medical need



European Journal of Preventive Cardiology 22(9): 1129-1138



Symptoms of depression and anxiety contribute to determining prognosis of patients with coronary heart disease. We evaluated the association of the one-year course of symptoms of anxiety and depressive symptoms with fatal and non-fatal cardiovascular disease-events during 10-year follow-up and assessed the utilization of anti-depressant and psycholeptic medication. Prospective cohort study in coronary heart disease patients aged 30-70 years with stable coronary heart disease. Symptoms of anxiety and depression were evaluated at baseline and follow-up using the Hospital Anxiety and Depression Scale. Associations with fatal and non-fatal cardiovascular disease events were determined by a Cox-proportional hazards model. Nine hundred and ninety-six patients were included in this study. Of the 862 patients with a normal depression symptom score at baseline 10.3% had an increased score at one-year follow-up. Of those with an elevated symptom score at baseline, 62.7% still had an elevated score after one year. During follow-up (median 8.9 years) fatal and non-fatal cardiovascular disease events were observed in 152 patients. One year course of depressive symptoms was associated with cardiovascular disease events during follow-up (p-value for trend 0.029); for example, patients with an increase of depressive symptoms had a hazard ratio of 1.93 (95% confidence interval 1.08-3.34) compared with patients with a normal score at baseline as well as at one-year follow-up. However, if physical activity was considered as a covariate, the HRs attenuated and the association was no longer statistically significant. The utilization of anti-depressant medication in the overall population was low (overall 2%). The study supports a role of the one year course of symptoms of depression for long-term prognosis of patients with known coronary heart disease, which might be partly mediated by lack of physical activity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055214482

Download citation: RISBibTeXText

PMID: 25070785

DOI: 10.1177/2047487314545317


Related references

Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links. European Journal of Cardiovascular Prevention and Rehabilitation 14(4): 547-554, 2007

Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease. Brain Behavior and Immunity 31: 183-188, 2013

Symptoms of depression and anxiety in patients with coronary heart disease: natural course and results of a psychotherapeutic pilot study. Zeitschrift für Psychosomatische Medizin und Psychotherapie 54(4): 381-392, 2008

Regular exercise behaviour and intention and symptoms of anxiety and depression in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey. European Journal of Preventive Cardiology 24(1): 84-91, 2017

Impact of anxiety and depression on prognosis in patients with coronary heart disease Results of a 1 year follow-up and consideration of various pathomechanistic links. American Journal of Epidemiology 157(11 Suppl.): S19, 2003

General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety- a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death. Health and Quality of Life Outcomes 9: 100, 2011

Exhaustion predicts coronary heart disease independently of symptoms of depression and anxiety in men but not in women. Journal of Psychosomatic Research 72(1): 17-21, 2012

Increased prevalence of anxiety and depression symptoms in patients with coronary artery disease before and after percutaneous coronary intervention treatment. Bmc Psychiatry 16: 259, 2016

Do Depressive Symptoms Moderate the Effects of Exercise Self-efficacy on Physical Activity Among Patients With Coronary Heart Disease?. Journal of Cardiovascular Nursing 33(4): E26-E34, 2018

Trajectories of depression and anxiety symptoms in coronary heart disease strongly predict health care costs. European Psychiatry 41: S312-S313, 2017

Study of Anxiety/Depression in Patients with Coronary Heart Disease After Percutaneous Coronary Intervention. Cell Biochemistry and Biophysics 72(2): 503-507, 2015

A Single, One-Off Measure of Depression and Anxiety Predicts Future Symptoms, Higher Healthcare Costs, and Lower Quality of Life in Coronary Heart Disease Patients: Analysis from a Multi-Wave, Primary Care Cohort Study. Plos one 11(7): E0158163, 2016

Easing depression and anxiety in people with heart disease. A six-month program decreased depression and led to fewer, less severe symptoms of heart disease. Harvard Heart Letter 24(11): 7-7, 2014

Accuracy and Prognostic Value of American Heart Association-Recommended Depression Screening in Patients With Coronary Heart Disease Data From the Heart and Soul Study. Circulation: Cardiovascular Quality and Outcomes 4(5): 533-540, 2011

Accuracy and prognostic value of American Heart Association: recommended depression screening in patients with coronary heart disease: data from the Heart and Soul Study. Circulation. Cardiovascular Quality and Outcomes 4(5): 533-540, 2012